Christopher J Barden

Title: Christopher J Barden: Innovator in Amyloid Protein Research

Introduction

Christopher J Barden is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biomedical research, particularly in the study of amyloid protein aggregation. With a total of six patents to his name, Barden's work has implications for understanding and treating various diseases.

Latest Patents

Barden's latest patents include innovative methods for identifying inhibitors of amyloid protein aggregation. These methods describe compounds that are either inhibitors or likely to be inhibitors of amyloid protein aggregation. Additionally, he has developed three-dimensional, non-crystallographic models, referred to as 'pseudo-crystal structures,' which are utilized in these methods. Another significant patent involves diphenyl substituted thiophene-2-amide derivatives and their pharmaceutical compositions, which are useful as antimicrobial agents.

Career Highlights

Throughout his career, Christopher J Barden has worked with several companies, including Treventis Corporation and Denouamed, Inc. His expertise in the field has allowed him to contribute to important research and development projects that advance our understanding of protein aggregation and its implications for health.

Collaborations

Barden has collaborated with notable colleagues, including Fan Wu and Erhu Lu. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the biomedical field.

Conclusion

Christopher J Barden's contributions to the field of amyloid protein research and his innovative patents highlight his role as a significant inventor. His work continues to influence the development of new therapeutic strategies for combating diseases associated with protein aggregation.